BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

20/05/2020 08:02

Biophytis Receives Approval from the Belgian Regulatory Agency (FAMHP) to Initiate COVA, a Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID19 Related Respiratory Failure

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

20/05/2020 08:00

Biophytis second AGM to take place on May 28, 2020 without the physical presence of its shareholders

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

19/05/2020 23:02

Biophytis shares resume trading following the implementation of measures ordered in connection with a dispute with NEGMA

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

11/05/2020 19:30

Biophytis - Convening of another combined General Meeting at a Later Date

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

07/05/2020 19:30

Biophytis shares and BSA trading is suspended pending a new press release

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

30/04/2020 19:00

Biophytis AGM meeting will take place on May 11, 2020 without the physical presence of its shareholders

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

27/04/2020 08:00

Biophytis Successfully Closes its Public Offering of Share Subscription Warrants (BSA)

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

21/04/2020 08:00

Correction - Biophytis launches a Public Offering of Share Subscription Warrants (BSA) with an Irreducible Priority Subscription Period for Existing Shareholders

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

07/04/2020 08:02

Biophytis Launches COVA Clinical Study with Sarconeos (BIO101) in Covid-19

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

07/04/2020 08:01

Biophytis Announces Launch of a Public Offering of Share Subscription Warrants (BSA) with an Irreducible Priority Subscription Period for Existing Shareholders

Voir tous les communiqués de BIOPHYTIS

1
2
3
4
5
6
7
8
9
10
»